Taladegib was shown to potently inhibit HH signaling in medulloblastoma cell lines, and significantly prolonged survival, and inhibited tumor growth of Ptch+/− p53−/− transgenic mice which spontaneously develop medulloblastoma [526]. The gene discussed is TP53; the disease is medulloblastoma.